IR820-PTX

Research use only, not for human use.

IR820-PTX is a nanoparticle composed of IR-820 and paclitaxel that is highly permeable and tumor-targeting.IR820-PTX can be used for near-infrared fluorescence imaging and tumor diagnostics.

IR820-PTX, an IR-820 (HY-136886)-Paclitaxel (HY-B0015) conjugate, is an amphipathic small molecule prodrug. IR820-PTX effectively inhibits tumor growth via combined photothermal therapy (PTT) and chemotherapy.

——

——

——

Others

Other Targets

Others

——

——

2250419-19-1

1780.07

C99H111N4NaO21S2

>98% (HPLC)

——

CC(O[C@]12[C@@]3([H])[C@@H]([C@]4(C(C)(C([C@H](C([C@@]3([C@H](C[C@@]1([H])OC2)O)C)=O)OC(C)=O)=C([C@H](C4)OC([C@H](OC(CCCCCNC5=C(C=CC6=[N+](C7=C(C8=CC=CC=C8C=C7)C6(C)C)CCCCS(=O)([O-])=O)CCCC5=CC=C9N(C%10=C(C%11=CC=CC=C%11C=C%10)C9(C)C)CCCCS(=O)([O-])=O)=O)[C@H](C%12=CC=CC=C%12)NC(C%13=CC=CC=C%13)=O)=O)C)C)O)OC(C%14=CC=CC=C%14)=O)=O.[Na+]

——

(-20℃)

With Ice Pack

≥ 2 years